We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Panel Discussion

Track:
A New Era for Medical Devices and Diagnostics. How Is The Impact?

Day & Time:
April 19, 10:30AM - 12:00PM (Central Europe Standard Time)

Session Number:
S0705

Room Number:
Boston 3

Type:
Session

Title:
Impact of Human Factors on the Development of Combination Products

Chair(s):
Muriel Didier
Human Factors Group Head
Novartis, Switzerland

Description:
Impact of Human Factors on the Development of Combination Products

Presentation(s) & Speaker(s):
Panel Discussion
Chin-Wei Soo, PhD
Global Regulatory Head - Combination Products and Devices
Genentech, United States

Panel Discussion
Lee Wood, MSc
Co-Founder and CEO
MedHF, Switzerland

Panel Discussion
Andrew Warrington
DayOneLab, Switzerland

Panel Discussion
Edward James Oakeley, PhD
Patient Advocate
Patient Advocate, Switzerland